Univation XM France

N/AWithdrawnNCT04199481

Aesculap AG

Overview

The study is set up due to regulatory purposes and to collect routine clinical data of the mobile-bearing implant univation XM. The study is designed as a prospective follow-up study with a historic patient cohort who have been treated with the product under investigation two years ago. This design is selected to quicker realize follow-up data as patients have already been treated in the past. As the mobile version of the implant is not widely used, the study will be set up as a monocentric study in France. The clinical hypothesis of the study is that patients who are treated with the product under investigation have a similar outcome and survival rate in comparison to other established unicondylar knee systems on the market. Comparison for the later evaluation will be taken out of recent orthopaedic registries.

Study Type

OBSERVATIONAL

Conditions

Osteoarthritis, Knee Osteoarthrosis of Knee Arthritis Knee Unicompartmental Knee Arthroplasty

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient has received a primary mobile bearing UKA at the study site between January 2017 and December 2018 using the product under investigation * Patient's written consent and willingness to participate at the clinical study and the follow-up examinations Exclusion Criteria: * Pregnancy * Patient Age \<18 years at the time of the surgery

Locations (1)

CHU Hopital Hautepierre

Strasbourg, France

Outcomes

Primary Outcomes

Survival Rate of the Implant

Revision-free survival rate after 5 years according to Kaplan-Meier

Time frame: 5 years after surgery

Secondary Outcomes

Development of Knee joint function

Postoperative Development of knee joint function measured with the Knee Society Score (KSS). The KSS is composed of two subgroups "Knee Score" and "Function Score"; both parts have a maximum score of 100, where higher values represent better results.

Time frame: in the postoperative course, up to 5 years after surgery

Development of Oxford Knee Score

A patient-reported outcome instrument which contains 12 questions on activities of daily living that assess function and residual pain in patients undergoing total knee replacement (TKR) arthroplasty. Oxford Knee Score has a maximum of 48 points indicating satisfactory knee function

Time frame: in the postoperative course, up to 5 years after surgery

Intraoperative/surgery Data

Surgical and intraoperative data collected will include the date and duration of the surgery, selected implants and sizes, blood loss and implant descriptions. Surgical duration is to be measured from the time of incision to the time of skin closure, skin-to-skin. All potential Adverse Events will be collected during the surgical procedure and/or from the surgical record and will be documented on the intra-operative Evaluation Form.

Time frame: intraoperative

Radiographic evaluation

The outcome and function of a knee prosthesis is influenced by the postoperative alignment of the leg and the orientation in reference to the axis. Incorrect positioning can lead to an increased implant wear and functional limitations; The aim of a postoperative alignment within 3° varus to 3° valgus will be assessed using long leg x-rays up to 5 years after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.